Olivia Kobayashi, PharmD, BCPS
Summary
Hospital clinical pharmacist at NYU Langone Tisch with 4 years post-PGY-1 residency. PharmD (NEU 2018) + NAPLEX (2019) + NY License #054312 (active through 2027) + DEA #FW9876543. BCPS-certified (2022). Verifies 280 orders/8-hour shift; documents 38 clinical interventions/shift with 84% acceptance. Antimicrobial stewardship rounds lead; co-authored 2024 antibiogram. APhA Pharmacy-Based Immunization Delivery certified.
Education & Training
- Rho Chi honor society. Graduate research focus on antimicrobial stewardship outcomes.
Licensure & Board Certification
Clinical Experience
- Verifies 280 medication orders/8-hour shift; documents 38 clinical interventions/shift (renal-dosing, drug-drug interaction, IV-PO conversion, antibiotic stewardship); intervention acceptance rate 84%.
- Antimicrobial stewardship: reviewed 480 patients/month with antimicrobial orders > 72 hours; recommended de-escalation or discontinuation on 138 (29%); reduced avg broad-spectrum days-of-therapy by 1.4 days/patient across the cohort.
- Order verification scope: TPN, chemotherapy (with BCOP support), pediatric dosing, renal-replacement-therapy adjustments, palliative care; verified 14,200 orders in 2024 with 4 verified-with-error events (all caught at the dispensing step).
- Co-authored the institution's 2024 antibiogram update; led antibiotic stewardship rounds (3x/week) with the ID team — 14 rounds led independently as the rounding pharmacist.
- Preceptor for 8 PharmD APPE rotations in 2024 across hospital + ambulatory settings; 2 students returned for PGY-1 residency match.
- Completed ASHP-accredited PGY-1; 6 longitudinal rotations + 1 staffing component (weekend hospital pharmacy coverage).
- Residency project: 'Implementation of pharmacist-led transitions-of-care service' (published in AJHP 2023 with co-authors).
- Earned APhA Pharmacy-Based Immunization Delivery cert + BLS during residency year.
Publications & Presentations
• Kobayashi O, Patel R, et al. 'Implementation of pharmacist-led transitions-of-care service at a 600-bed academic medical center.' Am J Health-Syst Pharm. 2023;80(14):892-901. • ASHP Midyear 2023 — Oral presentation, 'Antimicrobial stewardship interventions in an academic ICU' (co-presented with the ASP team). • Poster — 'TPN safety review redesign in oncology patients.' ASHP Midyear 2022.
Memberships & Languages
• American Society of Health-System Pharmacists (ASHP), member since 2018. • American College of Clinical Pharmacy (ACCP), member since 2020. • Society of Infectious Diseases Pharmacists (SIDP), member since 2022. Languages: English (native), Japanese (conversational).
Senior (Hospital Clinical, BCPS)
PharmD + BCPS. 280 verifications + 38 interventions/shift. PGY-1 residency.
Use this template